These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35455532)

  • 1. Formulation Challenges and Strategies to Develop Pediatric Dosage Forms.
    Malkawi WA; AlRafayah E; AlHazabreh M; AbuLaila S; Al-Ghananeem AM
    Children (Basel); 2022 Apr; 9(4):. PubMed ID: 35455532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues impacting therapeutic outcomes in pediatric patients: an overview.
    Kalra A; Goindi S
    Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
    Giacoia GP; Taylor-Zapata P; Mattison D
    Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European perspectives on pediatric formulations.
    Breitkreutz J
    Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.
    Tan DCT; Khong YM; Mount S; Galella E; Mitra B; Charlton S; Kuhli M; Ternik R; Walsh J; Rajapakshe A; Thompson K; Mehrotra S; Santangelo M; Liu J; Dixit T; Schaufelberger D; Jamzad S; Klein S; Hoag SW; Wang J; Fletcher EP; Khurana M; Alexander J; Radden E; Sood R; Selen A
    Eur J Pharm Biopharm; 2021 Jul; 164():54-65. PubMed ID: 33878432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buccal Dosage Forms: General Considerations for Pediatric Patients.
    Montero-Padilla S; Velaga S; Morales JO
    AAPS PharmSciTech; 2017 Feb; 18(2):273-282. PubMed ID: 27301872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral transmucosal drug delivery for pediatric use.
    Lam JK; Xu Y; Worsley A; Wong IC
    Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent landscape of pediatric-friendly oral dosage forms and administration devices.
    Karavasili C; Gkaragkounis A; Fatouros DG
    Expert Opin Ther Pat; 2021 Jul; 31(7):663-686. PubMed ID: 33605825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act: What can the obstetric community learn from the pediatric experience?
    Ren Z; Zajicek A
    Semin Perinatol; 2015 Nov; 39(7):530-1. PubMed ID: 26455383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric prescribing in tertiary care teaching hospital of Delhi (India): fragmenting medicines for use.
    Tayal H; Roy V; Singhal S; Dubey AP
    Eur J Pediatr; 2020 Sep; 179(9):1435-1443. PubMed ID: 32185474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
    Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
    Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposed pediatric biopharmaceutical classification system for medications for chronic diseases in children.
    Bhatt-Mehta V; Hammoud H; Amidon GL
    Eur J Pharm Sci; 2020 Sep; 152():105437. PubMed ID: 32598914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric drugs--a review of commercially available oral formulations.
    Strickley RG; Iwata Q; Wu S; Dahl TC
    J Pharm Sci; 2008 May; 97(5):1731-74. PubMed ID: 17823956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics.
    Zuccari G; Alfei S; Marimpietri D; Iurilli V; Barabino P; Marchitto L
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the pill: new medication delivery options for ADHD.
    Cutler AJ; Mattingly GW
    CNS Spectr; 2017 Dec; 22(6):463-474. PubMed ID: 28683846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.